Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience

BACKGROUND: Pseudoprogression (psPD) represents false radiologic evidence of tumor progression and is observed in some glioblastoma (GBM) patients after postoperative chemoradiation (CRT) with temozolomide (TMZ). The ambiguity of the psPD diagnosis confounds identification of true progression and ma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Pract
Autors principals: Mohammadi, Homan, Shiue, Kevin, Grass, G Daniel, Verma, Vivek, Engellandt, Kay, Daubner, Dirk, Schackert, Gabriele, Gondim, Mercia J, Gondim, Dibson, Vortmeyer, Alexander O, Kamer, Aaron P, Jin, William, Robinson, Timothy J, Watson, Gordon, Yu, Hsiang-Hsuan M, Lautenschlaeger, Tim
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318854/
https://ncbi.nlm.nih.gov/pubmed/32626587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz050
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars